Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
Gene-sequencing giant Illumina Inc (ILMN.O) has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina's genetic tests of infringing its patents. The
Ouster Inc, a San Francisco-based provider of lidar light sensors used in fields like autonomous vehicles, defense and robotics, sued Chinese rival Hesai Group for patent infringement in Delaware
patent infringement lawsuit against Charter Communications based upon improper venue. In re Charter Commc’ns, Inc., No. 2023-136 (Fed. Cir. Sept. 5, 2023). Although non-precedential, the decision
two other patents in the same family is final. For years, patent holder Illumina has been in dispute with Chinese biotechnology company MGI over various patents for DNA sequencing technology. Now the
specification may help illuminate the true focus of a claim, when analyzing patent eligibility, reliance on the specification must always yield to the claim language in identifying that focus.” Charge-Point, Inc.
The latest decision in the dispute between competitors Meril Life Sciences and Edwards Lifesciences has seen the District Court of The Hague revoke the Dutch claims of an Edwards patent and reject
carbon emissions created by fracking. Halliburton countersued U.S. Well Services in response to a patent lawsuit that it brought in 2021 over Halliburton's e-frac fleet. U.S. Well Services' patents from
department of biomedical engineering and mechanics. WHAT THEY DID Using a decade's worth of data from the NIH and the U.S. Patent and Trademark Office, the team created a database that linked utility
filed for a patent on a new order type now available within the company’s white label futures exchange solution. The order type, “Automatic Order Autonomy,” is said to offer a next level competitive
Numerous generic drug manufacturers may now enter the German market with their own fingolimod products. In a major blow for patent holder Novartis, Düsseldorf Higher Regional Court has overturned a
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
